2015 Opioid Overdose Summit Michael

[10:30 - 12:00pm] Clinical Practice Improvements

[3:35 - 4:30 pm] Panel Discussion: Unresolved Issues and Future Directions Grant Baldwin, PhD, MPH, Director of Division of ...

[1:20 - 2:20pm] Surveillance and Policy Responses Christina Porucznik, PhD, Associate Professor of Department of Family and ...

[2:20 - 3:20pm] Prevention of

1st speaker during the afternoon panel discussion [3:35 - 4:30pm] Grant Baldwin, PhD, MPH, Director of Division of Unintentional ...

[10:30 - 12:00pm] Clinical Practice Improvements Erin Krebs, MD, MPH, Core Investigator of Minneapolis VA Center for Chronic ...

[2:20 - 3:20pm] Prevention of

[8:45 - 9:00am] Welcome & Opening Remarks Jeffrey S. Desmond, MD, Interim Chief Medical Officer, Director of Clinical Quality ...

[9:45 - 10:15am] Non-Medical Use and "Medical Misuse" of

[9:00 - 9:45am] Epidemiology and the Scope of the Problem Grant Baldwin, PhD, MPH, Director of Division of Unintentional Injury ...

2nd speaker during the afternoon panel discussion [3:35 - 4:30pm] Aaron White, PhD, Senior Scientific Advisor, Office of the ...

[10:30 - 12:00pm] Clinical Practice Improvements Mark Ilgen, PhD, Clinical Psychologist of Department of Veterans Affairs Center ...

Closing remarks by Rebecca Cunningham, MD, Associate Chair for Research and Professor of Department of Emergency ...

[1:20 - 2:20pm] Surveillance and Policy Responses Tara Gomes, MHSc, Epidemiologist and Principal Investigator of Ontario

3rd speaker to present during the afternoon panel discussion [3:35 - 4:30pm] Jack Stein, PhD, MSW, Director of Office of Science ...

[8:45 - 9:00am] Welcome & Opening Remarks Rebecca Cunningham, MD, Associate Chair for Research and Professor of ...

How did we get here? Dr. Andrew Kolodny, one of the nation's leading experts on prescription

Panel 3 - Health System Approaches to

Brought to you by Dr. John Edwards, neurosurgeon at